Get the Stockscreener App
2.76
1.43%
-0.04
After Hours:
2.73
-0.03
-1.09%
Tela Bio Inc Stock (TELA) Latest News
Annovis Bio Raises $21 Million in Public Offering to Advance Alzheimer’s Research - MyChesCo
Annovis Bio Announces Public Offering of Common Stock and Warrants - MyChesCo
TELA Bio Inc to Host Earnings Call - ACCESS Newswire
TELA Bio Grants Inducement Stock Units to New Employees - MSN
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
TELA Bio Awards Equity Incentives to Seven New Strategic Hires - StockTitan
Jane Street Group LLC Sells 76,505 Shares of TELA Bio, Inc. (NASDAQ:TELA) - Defense World
TELA Bio, Inc. (NASDAQ:TELA) Shares Sold by Geode Capital Management LLC - Defense World
Retail investors account for 41% of TELA Bio, Inc.'s (NASDAQ:TELA) ownership, while institutions account for 28% - Yahoo Finance
TELA Bio, Inc. (NASDAQ:TELA) Shares Sold by State Street Corp - Defense World
TELA Bio (NASDAQ:TELA) Stock Price Down 0.3% – Here’s Why - Defense World
TELA Bio (NASDAQ:TELA) Stock Price Down 0.3%Should You Sell? - MarketBeat
TELA Bio Announces Inducement Grants for New Employees - MSN
TELA Bio's SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com Canada
TELA Bio's SWOT analysis: stock poised for growth amid challenges - Investing.com
TELA Bio Awards Strategic Inducement Grants to Secure Key New Talent - StockTitan
The past five years for TELA Bio (NASDAQ:TELA) investors has not been profitable - Yahoo Finance
Earnings call: TELA Bio reports strong Q3 growth, eyes future gains - Investing.com Nigeria
TELA Bio, Inc. (NASDAQ:TELA) Short Interest Down 29.8% in November - MarketBeat
TELA Bio Set to Unveil Innovations at Piper Sandler’s Premier Healthcare Conference! - MSN
GSA Capital Partners LLP Purchases 89,712 Shares of TELA Bio, Inc. (NASDAQ:TELA) - Defense World
TELA Bio to Present at Canaccord Genuity’s Growth Conference - MSN
TELA Bio Reports Strong Revenue Growth in Q3 2024 - MSN
TELA Bio to Participate in Piper Sandler's 36th Annual Healthcare Conference - The Manila Times
TELA Bio to Participate in Piper Sandler’s 36th Annual Healthcare Conference - GlobeNewswire
TELA Bio's SWOT analysis: innovative medical device stock faces growth hurdles - Investing.com India
TELA Bio, Inc. (NASDAQ:TELA) Sees Large Decline in Short Interest - MarketBeat
TELA Bio, Inc. (NASDAQ:TELA) Q3 2024 Earnings Call Transcript - Insider Monkey
TELA Bio Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Even With A 27% Surge, Cautious Investors Are Not Rewarding TELA Bio, Inc.'s (NASDAQ:TELA) Performance Completely - Simply Wall St
TELA Bio stock target cut, keeps overweight rating on Q3 results - Investing.com Nigeria
TELA Bio Inc (TELA) Quarterly 10-Q Report - Quartzy
Tela Bio price target lowered to $5 from $8 at Piper Sandler - TipRanks
Deep Dive Into TELA Bio Stock: Analyst Perspectives (6 Ratings) - Benzinga
Piper Sandler Has Lowered Expectations for TELA Bio (NASDAQ:TELA) Stock Price - MarketBeat
TELA Bio, Inc. (TELA) Reports Q3 Loss, Lags Revenue Estimates - MSN
TELA Bio Inc (TELA) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com
TELA Bio Inc (TELA) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance Australia
TELA Bio, Inc. Reports Record Revenue Growth - TipRanks
TELA Bio Inc Q3 2024 Earnings: Revenue Hits $19M, EPS at -$0.42, - GuruFocus.com
Tela Bio earnings missed by $0.02, revenue topped estimates - Investing.com UK
5.14%
2.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):